Janelsins Michelle C, Mastrangelo Michael A, Park Keigan M, Sudol Kelly L, Narrow Wade C, Oddo Salvatore, LaFerla Frank M, Callahan Linda M, Federoff Howard J, Bowers William J
Department of Microbiology and Immunology, Center for Neural Development and Disease, University of Rochester Medical Center, Rochester, NY 14642, USA.
Am J Pathol. 2008 Dec;173(6):1768-82. doi: 10.2353/ajpath.2008.080528. Epub 2008 Oct 30.
Inflammatory mediators, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta, appear integral in initiating and/or propagating Alzheimer's disease (AD)-associated pathogenesis. We have previously observed a significant increase in the number of mRNA transcripts encoding the pro-inflammatory cytokine TNF-alpha, which correlated to regionally enhanced microglial activation in the brains of triple transgenic mice (3xTg-AD) before the onset of overt amyloid pathology. In this study, we reveal that neurons serve as significant sources of TNF-alpha in 3xTg-AD mice. To further define the role of neuronally derived TNF-alpha during early AD-like pathology, a recombinant adeno-associated virus vector expressing TNF-alpha was stereotactically delivered to 2-month-old 3xTg-AD mice and non-transgenic control mice to produce sustained focal cytokine expression. At 6 months of age, 3xTg-AD mice exhibited evidence of enhanced intracellular levels of amyloid-beta and hyperphosphorylated tau, as well as microglial activation. At 12 months of age, both TNF receptor II and Jun-related mRNA levels were significantly enhanced, and peripheral cell infiltration and neuronal death were observed in 3xTg-AD mice, but not in non-transgenic mice. These data indicate that a pathological interaction exists between TNF-alpha and the AD-related transgene products in the brains of 3xTg-AD mice. Results presented here suggest that chronic neuronal TNF-alpha expression promotes inflammation and, ultimately, neuronal cell death in this AD mouse model, advocating the development of TNF-alpha-specific agents to subvert AD.
炎症介质,如肿瘤坏死因子-α(TNF-α)和白细胞介素-1β,在引发和/或传播阿尔茨海默病(AD)相关发病机制中似乎起着不可或缺的作用。我们之前观察到,在明显的淀粉样病理改变出现之前,三转基因小鼠(3xTg-AD)大脑中编码促炎细胞因子TNF-α的mRNA转录本数量显著增加,这与区域内小胶质细胞激活增强相关。在本研究中,我们发现神经元是3xTg-AD小鼠中TNF-α的重要来源。为了进一步确定神经元源性TNF-α在早期AD样病理过程中的作用,将表达TNF-α的重组腺相关病毒载体立体定向注射到2月龄的3xTg-AD小鼠和非转基因对照小鼠体内,以产生持续的局部细胞因子表达。在6月龄时,3xTg-AD小鼠表现出细胞内淀粉样β蛋白水平升高、tau蛋白过度磷酸化以及小胶质细胞激活的迹象。在12月龄时,3xTg-AD小鼠的TNF受体II和Jun相关mRNA水平均显著升高,并且观察到外周细胞浸润和神经元死亡,但在非转基因小鼠中未观察到。这些数据表明,在3xTg-AD小鼠大脑中,TNF-α与AD相关转基因产物之间存在病理相互作用。此处呈现的结果表明,在这个AD小鼠模型中,慢性神经元TNF-α表达会促进炎症,最终导致神经元细胞死亡,这支持开发TNF-α特异性药物来对抗AD。